Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19289999 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: cytarabine;   Drug: etoposide;   Drug: methotrexate;   Procedure: peripheral blood stem cell transplantation

Indicates status has not been verified in more than two years